TECH vs TRDA
Bio-Techne Corp (TECH) versus Entrada Therapeutics Inc (TRDA) — a side-by-side from cached financials, not a winner call.
Bio-Techne Corp (TECH) is a biotechnology company listed on US.
Entrada Therapeutics Inc (TRDA) is a biotechnology company listed on US.
Latest reported TECH revenue for 2025-06-30 was $1.22B. Net income was $73.4M. Revenue was up 5.2% from 2024-06-30 to 2025-06-30. TECH currently screens at market cap $8.49B and trailing P/E 65.2.
Latest reported TRDA revenue for 2024-12-31 was $210.8M. Net income was $65.6M. Revenue was up 63.4% from 2023-12-31 to 2024-12-31. TRDA currently screens at market cap $274.4M and trailing P/E 12.5.
TECH currently screens at market cap $8.49B and trailing P/E 65.2. TRDA currently screens at market cap $274.4M and trailing P/E 12.5.
Not investment advice. Open the TECH and TRDA stock pages for the full models.
Not investment advice.